Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
MAGHREB Pharma ExpoMAGHREB Pharma Expo
Not Confirmed
Not Confirmed
21-23 April, 2026
Not Confirmed
Not Confirmed
21-23 April, 2026
Not Confirmed
Not Confirmed
21-23 April, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
MAGHREB Pharma ExpoMAGHREB Pharma Expo
Industry Trade Show
Not Confirmed
21-23 April, 2026
Industry Trade Show
Not Confirmed
21-23 April, 2026
Industry Trade Show
Not Confirmed
21-23 April, 2026
Digital content

30 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/30/3264527/0/en/BridgeBio-Submits-NDA-to-FDA-for-BBP-418-for-Individuals-Living-with-LGMD2I-R9.html

30 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/30/3264934/0/en/Acoramidis-Significantly-Reduces-the-Risk-of-All-Cause-and-Cardiovascular-Mortality-in-Patients-with-ATTR-CM-through-Month-54.html

23 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/23/3260274/0/en/BridgeBio-to-Present-Long-Term-Efficacy-and-Safety-Data-from-the-ATTRibute-CM-OLE-Trial-at-the-ACC-Annual-Scientific-Sessions.html

20 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/20/3259940/0/en/BridgeBio-Pharma-Reports-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4.html

13 Mar 2026
// PRESS RELEASE
https://investor.bridgebio.com/news/news-details/2026/BBP-418-Demonstrates-Consistent-Efficacy-and-Favorable-Safety-Profile-in-Phase-3-FORTIFY-Interim-Analysis-in-LGMD2IR9/default.aspx

11 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/11/3254081/0/en/BBP-418-Demonstrates-Consistent-Efficacy-and-Favorable-Safety-Profile-in-Phase-3-FORTIFY-Interim-Analysis-in-LGMD2I-R9.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE